Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Current Diabetes Reports
Erschienen in: Current Diabetes Reports 1/2012

01.02.2012 | Diabetes and Pregnancy (CJ Homko, Section Editor)

Management of Diabetes in Pregnancy

verfasst von: Jerasimos Ballas, Thomas R. Moore, Gladys A. Ramos

Erschienen in: Current Diabetes Reports | Ausgabe 1/2012

Einloggen, um Zugang zu erhalten

Abstract

The link between diabetes and poor pregnancy outcomes is well established. As in the non-pregnant population, pregnant women with diabetes can experience profound effects on multiple maternal organ systems. In the fetus, morbidities arising from exposure to diabetes in utero include not only increased congenital anomalies, fetal overgrowth, and stillbirth, but metabolic abnormalities that appear to carry on into early life, adolescence, and beyond. This article emphasizes the newest guidelines for diabetes screening in pregnancy while reviewing their potential impact on maternal and neonatal complications that arise in the setting of hyperglycemia in pregnancy.
Literatur
1.
•• American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2010; 34 (Suppl 1):S62–69. This updates readers on the classification of and possible etiologies of diabetes mellitus.CrossRef
2.
•• International Association of Diabetes and Pregnancy Study Groups Consensus Panel. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care. 2010; 33(3): S76–S82. This is an update on the new recommendations for screening and diagnosing diabetes in pregnancy. It also notes that pregestational diabetes should be diagnosed in the first trimester.CrossRef
3.
The HAPO Study Cooperative Research Group. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med. 2008;358(19):1991–2002.CrossRef
4.
• The HAPO Study Cooperative Research Group. Hyperglycemia and Adverse Pregnancy Outcomes: associations with neonatal anthropometrics. Diabetes. 2009; 58(2): 453–459. This secondary analysis of the HAPO trial demonstrates the relationship between maternal hyperglycemia and neonatal anthropometric measurements, which adds support to the Pederson hypothesis.CrossRef
5.
Hillier TA, Vesco KK, Pedula KL, Beil TL, Whitlock EP, Pettitt DJ. Screening for gestational diabetes mellitus: a systematic review for the US preventive services task force. Ann Intern Med. 2008;148:766–75.PubMed
6.
Crowther CA, Jiller JE, Moss JR, McPhee AJ, Jeffries WS, Robinson JS. Australian Carbohydrate Intolerance Study Group in Pregnant Women (ACHOIS) trial group, effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med. 2005;352:2477–86.PubMedCrossRef
7.
•• Landon MB, Spong CY, Thom E, Carpenter MW, Ramin SM, Casey B, Wapner RJ, Varner MW, Rouse DJ, Thorp JM, Sciscione A, Catalano P, Harper M, Saade G, Lain KY, Lain KY, Sorokin Y, Peaceman AM, Tolosa JE, Anderson GB. A multicenter, randomized trial of treatment for mild gestational diabetes. N Engl J Med. 2009; 361(14): 1139–1148. This randomized control trial demonstrates that treatment of gestational diabetes is associated with lower rates of macrosomia and fat mass in the neonates of mothers with gestational diabetes.CrossRef
8.
Jovanovic-Peterson L, Peterson CM, Reed GF, et al. Maternal postprandial glucose levels and infant birth weight: the diabetes in early pregnancy study. Am J Obstet Gynecol. 1991;164:103–11.PubMed
9.
de Veciana M, Trail PA, Evans AT, et al. A comparison of oral acarbose and insulin in women with gestational diabetes mellitus. Am J Obstet Gynecol. 2002;99 Suppl 4:S5.
10.
Parretti E, Mecacci F, Papini M. Third trimester maternal glucose level from diurnal profiles in nondiabetic pregnancies—correlation with sonographic paramertes of fetal growth. Diabetes Care. 2001;24:1317–23.CrossRef
11.
Metzger BE, Buchanan TA, Coustan DR, de Leiva A, Dunger DB, Hadden DR, Hod M, Kitzmiller JL, Kjos SL, Oats JN, Pettitt DJ, Sacks DA, Zoupas C. Summary and recommendations of the fifth international workshop-conference on gestational diabetes mellitus. Diabetes Care. 2007;30:S251–60.PubMedCrossRef
12.
Zucker P, Simon G. Prolonged symptomatic neonatal hypoglycemia associated with maternal chlorpropamide therapy. Pediatrics. 1968;42:824–5.PubMed
13.
Towner D, Kjos SL, Leung B, et al. Congenital malformations in pregnancies complicated by NIDDM. Diabetes Care. 1995;18:1446–51.PubMedCrossRef
14.
Elliott BD, Schenker S, Langer O, et al. Comparative placental transport of oral hypoglycemic agents in humans: a model of human placental drug transfer. Am J Obstet Gynecol. 1994;171:653–60.PubMed
15.
Langer O, Conway D, Berkus M, et al. A comparison of glyburide and insulin in women with gestational diabetes mellitus. N Engl J Med. 2000;343:1134–8.PubMedCrossRef
16.
Chmait R, Dinise T, Daneshmand S, et al. Prospective cohort study to establish predictors of glyburide success in women with gestational diabetes mellitus. Am J Obstet Gynecol. 2001;185:S197.CrossRef
17.
Moore TR. Glyburide for the treatment of gestational diabetes: a critical appraisal. Diabetes Care. 2007;30:S209–13.PubMedCrossRef
18.
Jacobson GF, Ramos GA, Ching JY, et al. Comparison of glyburide and insulin for the management of gestational diabetes in a large managed care organization. Am J Obstet Gynecol. 2005;193:118–24.PubMedCrossRef
19.
Coustan DR. Pharmacological management of gestational diabetes: an overview. Diabetes Care. 2007;30:S206–8.PubMedCrossRef
20.
Hebert MF, Ma X, Naraharesetti SB, Krudys KM, Umans JG, Hankins GDV, Caritis SN, Miodovnik M, et al. Are we optimizing gestational diabetes treatment with Glyburide? The pharmacologic basis for better clinical practice. Clin Pharmacol Ther. 2009;85(6):607–14.PubMedCrossRef
21.
Legro RS, Barnhart HX, Schlaff WD, et al. Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome. N Eng J Med. 2007;356:551–66.CrossRef
22.
Coetzee EJ, Jackson WP. Metformin in management of pregnant insulin-independent diabetics. Diabetologia. 1979;16:241–5.PubMedCrossRef
23.
Hellmuth E, Damm P, Molsted-Pedersen L. Oral hypoglycaemic agents in 118 diabetic pregnancies. Diabet Med. 2000;17:507–11.PubMedCrossRef
24.
Hughes RC, Rowan JA. Pregnancy in women with type 2 diabetes: who takes metformin and what is the outcome? Diabet Med. 2006;23:318–22.PubMedCrossRef
25.
• Rowan J, Hague W, Gao W, Battin M, Moore P. Metformin versus insulin for the treatment of gestational diabetes. N Engl J Med. 2008; 358(19): 2003–2015. This discusses the first randomized trial of the use of metformin for the treatment of gestational diabetes.PubMedCrossRef
26.
Goh JE, Sadler L, Rowan J. Metformin for gestational diabetes in routine clinical practice. Diabet Med. 2011;28(9):1082–7.PubMedCrossRef
27.
Gabbe SG, Holing E, Temple P, et al. Benefits, risks, costs, and patient satisfaction associated with insulin pump therapy for the pregnancy complicated by type 1 diabetes mellitus. Am J Obstet Gynecol. 2000;182:1283–91.PubMedCrossRef
28.
Mukhopadhyay A, Farrell T, Fraser RB, Ola B. Continuous subcutaneous insulin infusion vs intensive conventional insulin therapy in pregnant diabetic women: a systematic review and metaanalysis of randomized, controlled trials. Am J Obstet Gynecol. 2007;197(5):447–56.PubMedCrossRef
29.
Moore TR, Catalano P. Diabetes in Pregnancy in Creasy RK, Resnik R, Iams JD, Lockwood CJ, Moore TR (Ed.), Creasy and Resnik’s maternal-fetal medicine: principles and practice (6th ed). 2009: 958–967
30.
Landon MB, Catalano PM, Gabbe SG. Diabetes mellitus in Gabbe SG, Niebyl JR, Simpson JL (Ed), Obstetrics, Normal and Problem Pregnancies (4th ed). 2002: 1089–1097.
31.
Sibai BM, Caritis S, Hauth J, et al. Risks of preeclampsia and adverse neonatal outcomes among women with pregestational diabetes mellitus. National institute of child health and human development network of maternal-fetal medicine units. Am J Obstet Gynecol. 2000;182:364–9.PubMedCrossRef
32.
Sibai BM, Ross MG. Hypertension in gestational diabetes mellitus: pathophysiology and long-term consequences. J Matern-Fetal Neo M. 2010;23(3):229–33.CrossRef
33.
Hawthorne G. Maternal complications in diabetic pregnancy. Best Pract Res CL OB. 2011;25:77–90.CrossRef
34.
American Diabetes Association. Nephropathy in diabetes—position statement. Diabetes Care. 2004;27(Supp 1):S79–83.
35.
Kitzmiller JL, Block JM, Brown FM, Catalano PM, et al. Managing preexisting diabetes for pregnancy: summary of evidence and consensus recommendations. Diabetes Care. 2008;31(5):1060–79.PubMedCrossRef
36.
Jensen DM, Damm P, Ovesen P, Molsted-Pedersen L, Beck-Nielsen H, Westergaard JG, Moeller M, Mathiesen ER. Microalbuminuria, preeclampsia, and preterm delivery in pregnant women with type 1 diabetes. Diabetes Care. 2010;33(1):90–4.PubMedCrossRef
37.
• Nielsen LR, Damm P, Mathiesen ER. Improved pregnancy outcome in type 1 diabetic women with microalbuniuria or diabetic nephropathy – effect of intensified antihypertensive therapy? Diabetes Care. 2009; 32(1): 38–44. This study highlights the importance of meticulous antihypertensive therapy as an adjunct to the treatment of DM1 in pregnancy.PubMedCrossRef
38.
Bhatnagar A, Ghauri AJ, Hope-Ross M, Lip PL. Diabetic retinopathy in pregnancy. Curr Diabetes Rev. 2009;5:151–6.PubMedCrossRef
39.
Kollias AN, Ulbig MW. Diabetic retinopathy—early diagnosis and effective treatment. Dtsch Artebl Int. 2010;107(5):75–84.
40.
Carroll MA, Yeomans ER. Diabetic ketoacidosis in pregnancy. Crit Care Med. 2005;33:S347–53.PubMedCrossRef
41.
Cullen MT, Reece EA, Homko CJ, et al. The changing presentations of diabetic ketoacidosis during pregnancy. Am J Perinatol. 1996;13:449.PubMedCrossRef
42.
American College of Obstetricians and Gynecologists (ACOG). Clinical management guidelines for obstetrician-gynecologists. ACOG practice bulletin no. 60: pregestational diabetes mellitus. Obstet Gynecol. 2005;105:675–85.CrossRef
43.
44.
45.
Miller E, Hare JW, Clohert JP, Dunn PJ, Gleason RE, Soeldner JS, Kitzmiller JL. Elevated hemoglobin A1C in early pregnancy and major congenital anomalies in infants with diabetic mothers. N Engl J Med. 1981;304(22):1331–4.PubMedCrossRef
46.
Becerra JE, Khoury MJ, Cordero JF, et al. Diabetes mellitus during pregnancy and the risks of specific birth defects: a population-based case–control study. Pediatrics. 1990;85:1–9.PubMed
47.
Correa A, Gilboa SM, Besser LM, Botto LD, Moore CA, Hobbs CA, Cleves MA, Riehle-Colarusso TJ, Waller DM, Reece A. Diabetes mellitus and birth defects. Am J Obstet Gynecol. 2008;237:e1–9.
48.
Anderson JL, Waller DM, Canfield MA, Shaw GM, Watkins ML, Werler MM. Maternal obesity, gestational diabetes, and central nervous system birth defects. Epidemiology. 2005;16(1):87–92.PubMedCrossRef
49.
Remsberg KE, McKeown RE, McFarland KF, Irwin LS. Diabetes in pregnancy and cesarean delivery. Diabetes Care. 1999;22:1561–7.PubMedCrossRef
50.
Keller JD, Lopez-Zeno JA, Dooley SL, Socol ML. Shoulder dystocia and birth trauma in gestational diabetes: a five-year experience. Am J Obstet Gynecol. 1991;165:928.PubMed
51.
Mimouni F, Miodovnik M, Rosenn B, et al. Birth trauma in insulin-dependent diabetic pregnancies. Am J Perinatol. 1992;9:205–8.PubMedCrossRef
52.
Nesbitt TS, Gilbert WM, Herrchen B. Shoulder dystocia and associated risk factors with macrosomic infants born in California. Am J Obstet Gynecol. 1998;179:476.PubMedCrossRef
53.
Langer O, Yogev Y, Most O, Xenakis EMJ. Gestational diabetes: the consequences of not treating. Am J Obstet Gynecol. 2005;192:989–97.PubMedCrossRef
54.
Ehrenberg HM, Mercer BM, Catalano PM. The influence of obesity and diabetes on the prevalence of macrosomia. Am J Obstet Gynecol. 2004;191:964–4.PubMedCrossRef
55.
Ogata ES, Sabbagha R, Metzger BE, et al. Serial ultrasonography to assess evolving fetal macrosomia: studies in 23 pregnant diabetic women. JAMA. 1980;243:2405.PubMedCrossRef
56.
Catalano PM, Thomas A, Huston-Presley L, Amini SB. Increased fetal adiposity: a very sensitive marker of abnormal in utero development. Am J Obstet Gynecol. 2003;189:1698–704.PubMedCrossRef
57.
American College of Obstetricians and Gynecologists (ACOG). Clinical management guidelines for obstetrician-gynecologists. ACOG practice bulletin no. 40: shoulder dystocia. Obstet Gynecol. 2002;100:1045–50.CrossRef
58.
Kjos SL, Walther FJ, Montoro M, et al. Prevalence and etiology of respiratory distress in infants of diabetic mothers: predictive value of fetal lung maturation tests. Am J Obstet Gynecol. 1990;163:898.PubMed
59.
Moore TR. A comparison of amniotic fluid fetal pulmonary phospholipids in normal and diabetic pregnancy. Am J Obstet Gynecol. 2002;186:641–50.PubMedCrossRef
60.
Boney CM, Verma A, Tucker R, Vohr BR. Metabolic syndrome in childhood: association with birth weight, maternal obesity, and gestational diabetes mellitus. Pediatrics. 2005;115:e290–6.PubMedCrossRef
61.
Parretti E, Mecacci F, Panini M, et al. Third trimester maternal glucose levels from diurnal profiles in nondiabetic pregnancies: correlation with sonographic parameters of fetal growth. Diabetes Care. 2001;24:1317.CrossRef
Metadaten
Titel
Management of Diabetes in Pregnancy
verfasst von
Jerasimos Ballas
Thomas R. Moore
Gladys A. Ramos
Publikationsdatum
01.02.2012
Verlag
Current Science Inc.
Erschienen in
Current Diabetes Reports / Ausgabe 1/2012
Print ISSN: 1534-4827
Elektronische ISSN: 1539-0829
DOI
https://doi.org/10.1007/s11892-011-0249-0

Weitere Artikel der Ausgabe 1/2012

Current Diabetes Reports 1/2012 Zur Ausgabe

Pediatric Type 2 Diabetes (M Freemark, Section Editor)

Pathogenesis and Prevention of Type 2 Diabetes: Parental Determinants, Breastfeeding, and Early Childhood Nutrition

Hospital Management of Diabetes (M Korytkowski, Section Editor)

Management of Hyperglycemia During the Perioperative Period

Diabetes and Pregnancy (CJ Homko, Section Editor)

The Placenta and Gestational Diabetes Mellitus

Invited Commentary

The Adjectives of Inpatient Glycemic Management

Hospital Management of Diabetes (M Korytkowski, Section Editor)

Basal-Bolus Insulin Protocols Enter the Computer Age

Diabetes and Pregnancy (CJ Homko, Section Editor)

Flavor Learning In Utero and Its Implications for Future Obesity and Diabetes

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise